Search

Your search keyword '"Rouleau, Jean L."' showing total 1,213 results

Search Constraints

Start Over You searched for: Author "Rouleau, Jean L." Remove constraint Author: "Rouleau, Jean L."
1,213 results on '"Rouleau, Jean L."'

Search Results

1. Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9—Pragmatic Research and Innovation through Multinational Experimentation

2. Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF

6. Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial

10. Abstract 13828: Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARADIGM-HF Proteomic Sub-Study

11. Abstract 12701: Safety and Tolerability of Angiotensin Receptor Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Drug Initiation Setting: A Subgroup Analysis of the PARADISE-MI Trial

12. Abstract 12470: Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m2: Insights From PARAGON-HF and PARADIGM-HF

15. Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy

16. Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction

19. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

21. High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT

23. Incidence and Outcomes of Pneumonia in Patients With Heart Failure

24. Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure

25. Pulmonary Congestion and Left Ventricular Dysfunction after Myocardial Infarction:Insights from the PARADISE-MI Trial

27. Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.

28. Independent prognostic importance of blood urea nitrogen (BUN) to creatinine ratio in heart failure

29. Abstract 12470: Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m 2 : Insights From PARAGON-HF and PARADIGM-HF

30. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

36. Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan.

37. Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan

38. Calcium channel blocker and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

42. Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) Trial

44. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

46. Knowledge about self‐efficacy and outcomes in patients with heart failure and reduced ejection fraction

47. Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan

48. Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with HFrEF and HFpEF

49. Clinical characteristics of HFrEF patients with rare pathogenic variants in DCM ‐associated genes: a subgroup analysis of the PARADIGM‐HF trial

50. Incremental prognostic value of biomarkers in PARADIGM‐HF

Catalog

Books, media, physical & digital resources